Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Key Stock Data
The current last sale of $1.25 is 22.55% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 1.27||$ 2.01|
|Low:||$ 1.22||$ 1.02|
Company Description (as filed with the SEC)
We research and develop biopharmaceutical products, including those based on our patented DNA delivery technologies, for the prevention and treatment of serious or life-threatening diseases. We currently have three active development programs in the area of infectious disease comprised of: * An ongoing Phase 2 trial of our HSV-2 therapeutic vaccine, VCL-HB01, to treat patients with symptomatic genital herpes infection. The vaccine candidate is currently being evaluated in a Phase 2 study in adult subjects, 18 to 50 years of age who are randomized 2:1 to receive either vaccine or placebo. Recruitment of 261 subjects at 15 U.S. clinical sites was completed in April 2017 and dosing was completed in July 2017. ... More ...
Nasdaq Official Price
Nov. 14, 2018
Nov. 13, 2018